Control Strategies for Synthetic Therapeutic Peptide APIs Part III: Manufacturing Process Considerations.
| Publicado en: | BioPharm International Vol. 27; no. 6; pp. 42 - 48 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Jun2014
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=103985218&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 103985218 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1542166X 5NE jtl: BioPharm International issn: 1542166X maglogo: N pubinfo: dt: Jun2014 vid: 27 iid: 6 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 103985218 2012674912 103985218 ppf: 42 ppct: 6 formats: fmt: @attributes: type: P tig: atl: Control Strategies for Synthetic Therapeutic Peptide APIs Part III: Manufacturing Process Considerations. aug: au: Eggen, Ivo Gregg, Brian Rode, Harold Swietlow, Aleksander Verlander, Michael Szajek, Anita affil: section lead global technical operations API chemistry, Aspen Pharma sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|